Could GLP-1 Therapy in Philadelphia PA Bring You the Long-Term Weight Loss You Have Been Fighting For?
Most people have no trouble gaining weight. Yet reducing weight is not so simple. Anybody who has attempted dieting knows that while the adds talk a great game, getting results is far harder to come by in this $33 billion market. But now, everything might change. GLP-1 Therapy in Philadelphia PA is finally showing some promise on the weight loss front.
Get the Facts About GLP-1 Therapy in Philadelphia PAn MA
Related to GLP-1 (short for glucagon-like peptide-1), semaglutide works by affecting the parts of the brain that control your gut, appetite, and fullness. Also, it affects how quickly your stomach will empty throughout digestion.
The initial approval and use of GLP-1 Therapy in Philadelphia PA was for type 2 diabetes. But, weight loss was rapidly identified as an additional advantage by researchers. During the trials for the drug, the average person lost nearly 13% of their body weight. More than a third of trial participants lost 20% of their body weight.
Is There a Downside to GLP-1 Therapy in Philadelphia PA?
Constipation, diarrhea, nausea, and exhaustion are the most prevalent side effects. But, by merely changing the dosage, these side effects were largely eliminated. The only alternative medical weight loss strategy that, as of yet, produces outcomes equal to semaglutide is bariatric surgery. Semaglutide is a safer alternative to bariatric surgery due to the fact that it bariatric surgery involves a major surgery.
What Do the Stats Say? GLP-1 Therapy in Philadelphia PA Really Works
All of the above probably sounds too good to be true. We know you don’t want to fall for yet another “miracle” drug that won’t come close to living up to expectations. Following is some of the data learned from the drug trials. Over the course of 52 weeks, a study designed to find the semaglutide dosages that work best discovered weight reduction of up to 16.2% relative to baseline. The average research participant shed 37 pounds, resulting in a 12% reduction in their initial body weight.
A study that included lifestyle and diet changes found a 2.4% weight loss in the placebo group, compared to 15-20% loss in those taking semaglutide.
Being Overweight Comes with Many Complications
A person who is overweight may be more susceptible to major health problems. Specific examples include type 2 diabetes, high blood pressure, high cholesterol (especially LDL or “bad” cholesterol), heart disease and stroke, fatty liver and gallbladder disease, cancer (especially breast and colon cancer), sleep apnea, arthritis (especially in weight-bearing joints), and lower back pain.
Are You Having a Hard Time Shedding Pounds?
We at Renew Youth are here to assist you in locating the solution, which may be GLP-1 Therapy in Philadelphia PA. Contact us at 800-859-7511 or complete our online contact form to schedule a free consultation and learn more about the option.